StreetInsider.com News Articles

MustGrow Closes $3.7 Million Non-Brokered LIFE Offering

Fri, 19 Jun 2026 17:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - June 19, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the closing of its previously announced non-brokered private placement of 7,481,541 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of approximately $3,741,000 (the "LIFE Offering").

Each Unit consists of (i) one common share of the Company (each, a "Common Share") and (ii) one common share purchase warrant (each, a "Warrant"). Each whole Warrant will be exercisable for a period of 60 months from the date of

MustGrow Closes $3.7 Million Non-Brokered LIFE Offering

Fri, 19 Jun 2026 17:00:00 -0400

MustGrow Announces First Quarter 2026 Financial Results

Thu, 28 May 2026 17:00:00 -0400

Investor Webcast: Friday, May 29^th at 4:00pm ET / 1:00pm PT
Register/View Here: https://us02web.zoom.us/webinar/register/7717781882447/WN_m6cQAgeQSD6hjP6JeVpfbw
Please join/register at least 5 minutes prior to the call. Email questions before 2:00pm ET to info@mustgrow.ca, which will be addressed during the Q&A portion of the webcast.

Saskatoon, Saskatchewan--(Newsfile Corp. - May 28, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended March 31, 2026. For complete details, please refer to the condensed interim

MustGrow Announces First Quarter 2026 Financial Results

Thu, 28 May 2026 17:00:00 -0400

MustGrow Announces Non-Brokered LIFE Offering of Approximately $2 Million

Mon, 25 May 2026 18:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - May 25, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce a non-brokered private placement of units (each, a "Unit") at a price of $0.50 per Unit for aggregate gross proceeds to the Company of approximately $2,000,000 (the "LIFE Offering"). The Company reserves the right to increase the size of the Offering, as further described in the offering document.

Each Unit will consist of: (i) one common share in the capital of the Company (each, a "Common Share"); and (ii) one Common Share purchase warrant (each, a

MustGrow Announces Non-Brokered LIFE Offering of Approximately $2 Million

Mon, 25 May 2026 18:00:00 -0400

Each Unit will consist of: (i) one common share in the capital of the Company (each, a "Common Share"); and (ii) one Common Share purchase warrant (each, a

MustGrow Receives Texas, Utah, and Montana Registrations for TerraSante(TM) Biofertility Product

Mon, 25 May 2026 07:00:00 -0400

MustGrow has received approval from the agriculture departments of Texas, Utah, and Montana to commence sales of organic biofertility product TerraSante^TM.
Based on infield grower data, the mustard-derived TerraSante^TM biofertility product has been shown to improve crop yields, soil, and potentially the soil microbiome health for nutrient/water use efficiencies.

Saskatoon, Saskatchewan--(Newsfile Corp. - May 25, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce registration approvals from the Texas Department of Agriculture, the Utah Department of Agriculture and Food, and the Montana Department of Agriculture for its mustard plant-based TerraSante^TM,

MustGrow Receives Texas, Utah, and Montana Registrations for TerraSante(TM) Biofertility Product

Mon, 25 May 2026 07:00:00 -0400

MustGrow has received approval from the agriculture departments of Texas, Utah, and Montana to commence sales of organic biofertility product TerraSante^TM.
Based on infield grower data, the mustard-derived TerraSante^TM biofertility product has been shown to improve crop yields, soil, and potentially the soil microbiome health for nutrient/water use efficiencies.

Saskatoon, Saskatchewan--(Newsfile Corp. - May 25, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce registration approvals from the Texas Department of Agriculture, the Utah Department of Agriculture and Food, and the Montana Department of Agriculture for its mustard plant-based TerraSante^TM,

MustGrow Announces Market Awareness Services and Investor Relations Agreements

Thu, 14 May 2026 17:14:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - May 14, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") announces the following market awareness services and investor relations agreements to increase visibility and awareness to MustGrow. Disclosure is made in accordance with the requirements of the TSX Venture Exchange (the "TSXV").

Market One Media Group

MustGrow has entered into a media services agreement with Market One Media Group Inc. ("Market One") dated January 13, 2026 (the "Market One Agreement"). Market One, with offices in Vancouver and Toronto, is a multiplatform media solution for the capital markets operating in editorial, video,

MustGrow Announces Market Awareness Services and Investor Relations Agreements

Thu, 14 May 2026 17:14:00 -0400

Market One Media Group

MustGrow Announces 2025 Financial Results

Wed, 29 Apr 2026 17:00:00 -0400

Investor Webcast: Thursday, April 30^th at 4:00pm ET / 1:00pm PT
Register/View Here: https://us02web.zoom.us/webinar/register/3117774401744/WN_eXcymymWSnicArxMPOiZVA
Please join/register at least 5 minutes prior to the call.
Questions emailed to info@mustgrow.ca will be addressed during the Q&A portion of the webcast.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 29, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, announces its audited financial results for the year ended December 31, 2025. For complete details, please refer to the Audited 2025 Financial Statements and associated Management's Discussion and Analysis, available

MustGrow Announces 2025 Financial Results

Wed, 29 Apr 2026 17:00:00 -0400

MustGrow Receives Georgia Registration for TerraSante(TM) Biofertility Product

Tue, 28 Apr 2026 07:00:00 -0400

MustGrow has received approval from the Georgia Department of Agriculture to commence sales of TerraSante^™, an organic biofertility product, in the State of Georgia.
Mustard-derived TerraSante™ has been shown to improve crop yields, soil and soil microbiome health, and nutrient/water use efficiencies.

Saskatoon, Saskatchewan--(Newsfile Corp. - April 28, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce receipt of the Georgia Department of Agriculture registration approval for its mustard plant-based TerraSante^™, an organic biofertility product. The Georgia organic certification is included under MustGrow's existing Organic OMRI Listed^® certifications in Florida, Arizona, Idaho,

MustGrow Receives Georgia Registration for TerraSante(TM) Biofertility Product

Tue, 28 Apr 2026 07:00:00 -0400

MustGrow has received approval from the Georgia Department of Agriculture to commence sales of TerraSante^™, an organic biofertility product, in the State of Georgia.
Mustard-derived TerraSante™ has been shown to improve crop yields, soil and soil microbiome health, and nutrient/water use efficiencies.

MustGrow's Canola Field Trials Demonstrate Clubroot Disease Suppression; Improved Canola Yield with Healthier Root Systems

Tue, 03 Feb 2026 10:37:00 -0400

MustGrow's mustard-derived organic biocontrol technology TerraMG^TM focuses on soil-borne disease and pest suppression, which has been shown to improve soil conditions, crop yields, and healthier root systems;
Clubroot is a soil-borne parasitic disease with devastating effects on canola production across the Canadian Prairies with no effective products currently registered for Clubroot suppression;
Field trial findings support TerraMG^TM's role as a sustainable product capable of suppressing Clubroot and promoting higher canola yields and root systems under various disease pressures;
MustGrow (via NexusBioAg) trialed approx. 100 acres over 2-year field program.

Saskatoon, Saskatchewan--(Newsfile Corp. - February 3, 2026) - MustGrow Biologics Corp. (TSXV: MGRO)

MustGrow's Canola Field Trials Demonstrate Clubroot Disease Suppression; Improved Canola Yield with Healthier Root Systems

Tue, 03 Feb 2026 10:37:00 -0400

MustGrow's mustard-derived organic biocontrol technology TerraMG^TM focuses on soil-borne disease and pest suppression, which has been shown to improve soil conditions, crop yields, and healthier root systems;
Clubroot is a soil-borne parasitic disease with devastating effects on canola production across the Canadian Prairies with no effective products currently registered for Clubroot suppression;
Field trial findings support TerraMG^TM's role as a sustainable product capable of suppressing Clubroot and promoting higher canola yields and root systems under various disease pressures;
MustGrow (via NexusBioAg) trialed approx. 100 acres over 2-year field program.
Saskatoon, Saskatchewan--(Newsfile Corp. - February 3, 2026) - MustGrow Biologics Corp. (TSXV: MGRO)

MustGrow Closes $2.0 Million Non-Brokered LIFE Offering

Fri, 23 Jan 2026 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - January 23, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce: the closing of its previously annoucned non-brokered private placement of 4,000,000 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of $2,000,000 (the "LIFE Offering").
Each Unit consists of (i) one common share of the Company (a "Share") and (ii) one common share purchase warrant (a "Warrant"). Each whole Warrant will be exercisable for a period of 60 months from the date of closing and will entitle the

MustGrow Closes $2.0 Million Non-Brokered LIFE Offering

Fri, 23 Jan 2026 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - January 23, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce: the closing of its previously annoucned non-brokered private placement of 4,000,000 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of $2,000,000 (the "LIFE Offering").
Each Unit consists of (i) one common share of the Company (a "Share") and (ii) one common share purchase warrant (a "Warrant"). Each whole Warrant will be exercisable for a period of 60 months from the date of closing and will entitle the

MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million

Thu, 08 Jan 2026 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - January 8, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce a non-brokered private placement of up to 4,000,000 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of up to $2,000,000 (the "LIFE Offering").
Each Unit will consist of (i) one common share of the Company (a "Share"); and (ii) one common share purchase warrant (a "Warrant"). Each whole Warrant will be exercisable for a period of 60 months from the Closing Date (defined below) and will entitle the

MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million

Thu, 08 Jan 2026 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - January 8, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce a non-brokered private placement of up to 4,000,000 units of the Company (each, a "Unit") at a price of $0.50 per Unit for gross proceeds of up to $2,000,000 (the "LIFE Offering").
Each Unit will consist of (i) one common share of the Company (a "Share"); and (ii) one common share purchase warrant (a "Warrant"). Each whole Warrant will be exercisable for a period of 60 months from the Closing Date (defined below) and will entitle the

MustGrow: CEO Letter to Shareholders 2025

Thu, 18 Dec 2025 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - December 18, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to issue a letter to shareholders from Corey Giasson, MustGrow's President and CEO.
Dear MustGrow shareholders and stakeholders,
I hope everyone is well and ready to enjoy a peaceful and festive holiday season with family and friends. I am writing this letter to share our excitement in what was a truly transformational year for MustGrow as we transitioned from product development to commercialization, with our own mustard-derived TerraSante^TM biofertility product sales expansion in the U.S. and

MustGrow: CEO Letter to Shareholders 2025

Thu, 18 Dec 2025 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - December 18, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to issue a letter to shareholders from Corey Giasson, MustGrow's President and CEO.
Dear MustGrow shareholders and stakeholders,
I hope everyone is well and ready to enjoy a peaceful and festive holiday season with family and friends. I am writing this letter to share our excitement in what was a truly transformational year for MustGrow as we transitioned from product development to commercialization, with our own mustard-derived TerraSante^TM biofertility product sales expansion in the U.S. and

MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)

Wed, 10 Dec 2025 07:00:00 -0400

Mustard-derived organic TerraSante^TM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies;
Large scale field trial showed 2 ton per acre yield increase with larger size potatoes and less culls equating to approximately US$5,000 increase in value per acre; and
Significant soil health benefit when applied in combination with the current grower standard program.
Saskatoon, Saskatchewan--(Newsfile Corp. - December 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce outstanding performance metrics on its organic TerraSante^TM biofertility product

MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)

Wed, 10 Dec 2025 07:00:00 -0400

Mustard-derived organic TerraSante^TM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies;
Large scale field trial showed 2 ton per acre yield increase with larger size potatoes and less culls equating to approximately US$5,000 increase in value per acre; and
Significant soil health benefit when applied in combination with the current grower standard program.
Saskatoon, Saskatchewan--(Newsfile Corp. - December 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce outstanding performance metrics on its organic TerraSante^TM biofertility product

MustGrow Announces Record Q3-2025 Results

Tue, 25 Nov 2025 16:00:00 -0400

Investor Webcast: Wednesday, November 26th at 4:00pm ET / 1:00pm PT.
Register/View Here: https://us02web.zoom.us/webinar/register/8617635107958/WN_Ka6aNlTZTLuCJPaetQoLuQ.
Please join/register at least 5 minutes prior to the call.
Questions emailed to info@mustgrow.ca will be addressed during the Q&A portion of the webcast.
Saskatoon, Saskatchewan--(Newsfile Corp. - November 25, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended September 30, 2025. For complete details, please refer to the Q3-2025 Condensed Interim Financial Statements